Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

alifornia and Texas, which reported a combined increase of about 576,000 on an unadjusted basis," while Florida "showed a decline of about 122,000." Jo Ling Kent of NBC Nightly News <https://playvideo.bulletinintelligence.corn/e81410521a064cb6a54112865366e50b?pubid=fbi> (7/30, story 7, 1:00, Holt, 5.82M) pro

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

alifornia and Texas, which reported a combined increase of about 576,000 on an unadjusted basis," while Florida "showed a decline of about 122,000." Jo Ling Kent of NBC Nightly NewsVi (7/30, story 7, 1:00, Holt, 5.82M) provided similar coverage, as did the CBS Evening NewsVi (7/30, story 7, 0:50, O'Donnell,

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

alifornia and Texas, which reported a combined increase of about 576,000 on an unadjusted basis," while Florida "showed a decline of about 122,000." Jo Ling Kent of NBC Nightly NewsVI (7/30, story 7, 1:00, Holt, 5.82M) provided similar coverage, as did the CBS Evening NewsVi (7/30, story 7, 0:50, O'Donnell,